Polaris Capital Management’s Harmony Biosciences HRMY Stock Holding History

Polaris Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Hold	36,100	–	–	0.12%	77
2026 Q1	$1.01M	Hold	36,100	–	–	0.08%	77
2025 Q4	$1.35M	Hold	36,100	–	–	0.11%	71
2025 Q3	$995K	Hold	36,100	–	–	0.07%	80
2025 Q2	$1.14M	Hold	36,100	–	–	0.08%	81
2025 Q1	$1.2M	Sell	36,100 -22,200	-38%	-$796K	0.07%	76
2024 Q4	$2.01M	Buy	58,300 +13,300	+30%	+$457K	0.1%	56
2024 Q3	$1.8M	Buy	45,000 +16,500	+58%	+$580K	0.09%	66
2024 Q2	$860K	Hold	28,500	–	–	0.05%	83
2024 Q1	$957K	Hold	28,500	–	–	0.05%	80
2023 Q4	$921K	Sell	28,500 -7,600	-21%	-$212K	0.04%	82
2023 Q3	$1.18M	Hold	36,100	–	–	0.06%	70
2023 Q2	$1.27M	Hold	36,100	–	–	0.05%	74
2023 Q1	$1.18M	Buy	36,100 +4,300	+14%	+$196K	0.04%	75
2022 Q4	$1.75M	Buy	31,800 +3,300	+12%	+$181K	0.06%	55
2022 Q3	$1.26M	Hold	28,500	–	–	0.05%	63
2022 Q2	$1.39M	Sell	28,500 -2,400	-8%	-$108K	0.05%	57
2022 Q1	$1.5M	Hold	30,900	–	–	0.05%	62
2021 Q4	$1.32M	Hold	30,900	–	–	0.04%	71
2021 Q3	$1.18M	Hold	30,900	–	–	0.04%	78
2021 Q2	$872K	Buy	+30,900	New	+$927K	0.03%	92

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polaris Capital Management's HRMY Position: Q2 2026 in Review

Polaris Capital Management held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 36,100 shares worth $1.31M. The position accounts for 0.12% of the portfolio, ranked #77.

Polaris Capital Management first reported a position in HRMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.01M in Q4 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Polaris Capital Management held 36,100 shares of Harmony Biosciences worth $1.31M as of Q2 2026.
Polaris Capital Management left its Harmony Biosciences share count unchanged in Q2 2026.
Harmony Biosciences made up 0.12% of Polaris Capital Management's portfolio in Q2 2026, its #77 holding.
Polaris Capital Management first reported a position in Harmony Biosciences in Q2 2021 and has held it in 21 quarters since.
Polaris Capital Management's Harmony Biosciences position peaked at $2.01M in Q4 2024.
328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.